AB0392 Safety and Tolerability of Iguratimod in Rheumatoid Arthritis with Comorbid Illnesses
Volume: 75, Issue: Suppl 2, Pages: 1039.2 - 1039
Published: Jun 1, 2016
Abstract
Background
Iguratimod, a member of the family of methanesulfonanilide, is a relatively new oral anti-rheumatic medication. Although most of the members of this family act as cyclooxygenase 2 inhibitor, iguratimod has been considered to be a novel immunomodulator agent. Little data exists regarding its safety and tolerability in patients with comorbid illnesses.Objectives
To determine the safety and retention rate of Iguratimod...Paper Details
Title
AB0392 Safety and Tolerability of Iguratimod in Rheumatoid Arthritis with Comorbid Illnesses
Published Date
Jun 1, 2016
Volume
75
Issue
Suppl 2
Pages
1039.2 - 1039
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History